Atlas Trials

Study to Investigate the Effect of AB-101 in Breast Cancer Survivors

Clinical trial NCT03592121 · COMPLETED

Trial details

NCT number
NCT03592121
Sponsor
Applied Biology, Inc.
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Sexual DysfunctionSexual Arousal DisorderSexual Dysfunction, PhysiologicalBreast CancerNipple DisorderNeuropathyCancer of Breast
Start date
2018-07-09
Primary completion
2019-10-12
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.